Economy
Eli Lilly profits more than double as weight-loss drug sales soar
First-quarter sales of medication Zepbound increased 80 per cent to $4.2bn
F
Financial Times
April 30, 2026·1 min read
Image: Financial Times
First-quarter sales of medication Zepbound increased 80 per cent to $4.2bn
Original article
Eli Lilly profits more than double as weight-loss drug sales soar
Published by Financial Times